Elanix Biotechnologies AG
Develops products from progenitor cells for wound care and dermatological applications.
ELN | F
Overview
Corporate Details
- ISIN(s):
- DE000A0WMJQ4
- LEI:
- 391200SYNFFL0NPAJK90
- Country:
- Germany
- Address:
- Hanauer Landstrasse 291, 60314 Frankfurt am Main
- Sector:
- Manufacturing
Description
Elanix Biotechnologies AG is a tissue regeneration company that develops and commercializes products for acute wound care, dermatological, and gynecological applications. The company's core focus is on creating therapeutic solutions derived from progenitor cells. Its product development pipeline aims to provide advanced treatments for skin and tissue repair.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2018-04-30 20:44 |
Elanix Biotechnologies AG secures up to EUR 2.5 Million SEDA (Standby Equity Di…
|
English | 11.5 KB | ||
| 2018-02-20 13:29 |
Release according to Article 41 of the WpHG [the German Securities Trading Act]…
|
English | 3.9 KB | ||
| 2018-02-14 11:48 |
Elanix Biotechnologies AG Raises EUR 1.125 Million gross proceeds from Complete…
|
English | 13.0 KB | ||
| 2018-02-14 11:01 |
Elanix Biotechnologies AG: Elanix Biotechnologies AG places a total of 300,019 …
|
English | 10.5 KB | ||
| 2018-01-23 08:00 |
Elanix Biotechnologies AG Appoints Baader Bank as a New Designated Sponsor and …
|
English | 9.1 KB | ||
| 2017-12-27 08:00 |
Elanix's Partner Transwell Biotech Completes Phase I of Phase I/II Clinical Tri…
|
English | 8.2 KB | ||
| 2017-12-12 08:31 |
Elanix Biotechnologies AG Announces Continuation of Private Placement at Subscr…
|
English | 11.5 KB | ||
| 2017-12-01 08:00 |
Elanix Biotechnologies Signs Agreement with Dermacon to Develop Progenitor Cell…
|
English | 8.6 KB | ||
| 2017-11-23 20:09 |
DGAP-DD: Elanix Biotechnologies AG english
|
English | 7.7 KB | ||
| 2017-11-23 20:07 |
DGAP-DD: Elanix Biotechnologies AG english
|
English | 7.0 KB | ||
| 2017-11-23 16:18 |
Elanix Biotechnologies AG to Present at German Equity Forum 2017
|
English | 9.0 KB | ||
| 2017-11-22 08:22 |
Elanix Biotechnologies AG Announces Subscription Period and Subsequent Private …
|
English | 12.2 KB | ||
| 2017-11-10 16:32 |
Elanix Biotechnologies AG: Announces Subscription Price for New Shares in Capit…
|
English | 12.0 KB | ||
| 2017-10-17 12:48 |
Elanix Biotechnologies AG: Agreement in principle reached on the conditions for…
|
English | 9.5 KB | ||
| 2017-09-29 08:00 |
Elanix Biotechnologies Announces First Half 2017 Financial Results
|
English | 11.7 KB |
Automate Your Workflow. Get a real-time feed of all Elanix Biotechnologies AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Elanix Biotechnologies AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Elanix Biotechnologies AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
